Influence of overall and abdominal adiposity on C-reactive protein levels in elderly women;Influência da adiposidade global e da adiposidade abdominal nos níveis de proteína C-reativa em mulheres idosas

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 4, 2007, Pages 231-236

  Sasaki, Jeffer Eidi ^a,b   Krause, Maressa Priscila ^a   Gama, Mirnaluci P R ^a   Hallage, Tatiane ^a   Buzzachera, Cosme Franklin ^a   Dos Santos, Maria Gisele ^a   Da Silva, Sergio Gregorio ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

Adiposity; Atherosclerosis; Risk factors; Women

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL OBESITY; AGED; ANALYSIS OF VARIANCE; ARTICLE; BODY FAT; BODY MASS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREDICTION; PREDICTOR VARIABLE; PROTEIN BLOOD LEVEL; RISK; SAMPLE; SKINFOLD; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADIPOSITY; AGED; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MIDDLE AGED; NEOPLASMS; ODDS RATIO; SKINFOLD THICKNESS; TENDINOPATHY; WAIST-HIP RATIO;

EID: 37349014102     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ross R. The pathogenesis of atherosclerosis. In: Braunwald E. (ed.). Heart disease. A Textbook of cardiovascular medicine. 4th ed. Philadelphia (PA): W. B. Saunders Company; 1992. p. 1106-23.
2. Camarano AA. O envelhecimento da população brasileira: uma contribuição demográfica. São Paulo: Instituto de Pesquisa e Estatística Aplicada - IPEA; 2002. p. 1-97.
3. Boyle EM, Lille ST, Allaire E, Clowes AW, Verrier ED. Atherosclerosis. Ann Thorac Surg. 1997; 64: 47-56.
4. Affiune A. Envelhecimento cardiovascular. In: Freitas EV, Py L, Neri AL, Cançado F, Gorzoni ML, Rocha M. (eds.). Tratado de geriatria e gerontologia. Rio de Janeiro: Guanabara Koogan; 2002.
5. Bhattacharrya G, Libby P. In: Lilly LS. Atherosclerosis: pathophysiology of heart disease. 2nd ed. Pennsylvania (USA): Lippincott Williams & Wilkins; 1998. p. 101-18.
6. Taddei CFG, Franken RA. Aterosclerose: fisiopatologia e prevenção de fatores de risco. In: Freitas EV, Py L, Neri AL, Cançado F, Gorzoni ML, Rocha M. Tratado de geriatria e gerontologia. Rio de Janeiro: Guanabara Koogan; 2002.
7. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in the risk assessment. Am J Med. 2004; 116 (6A): 9S-16S.
8. Pepsys MB, Berger A. The renaissance of C-reactive protein. Br Med J. 2001; 321: 4-5.
9. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis. 2003; 167: 73-9.
10. Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol. 2004; 21: 1509-15.
11. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999; 22 (12): 1971-7.
12. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000; 149: 139-50.
13. Mendall MA, Strachan DP, Butland BK, Ballam L, Morris J, Sweetnam PM, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 2000; 21: 1584-90.
14. Rawson E, Freedson PS, Osganian SK, Matthews CE, Reed G, Ockene I. Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc. 2003; 35 (7): 1160-6.
15. Vikram NK, Misra A, Dwivedi M, Sharma R, Pandey RM, Luthra K, et al. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat, and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis. 2003; 168: 305-13.
16. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease. Am J Hypertens. 2004; 17: 568-73.
17. Lakka T, Lakka HM, Salonen R, Kaplan GA, Salonen JT. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis. 2001; 154: 497-504.
18. Heillbronn LK, Clifton PM. C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss. J Nutr Biochem. 2002; 13: 316-21.
19. Hak AE, Stehower CDA, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis, in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 1999; 19: 1986-91.
20. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual abridged edition. Champaign (IL): Human Kinetics; 1988.
21. Jackson AS, Pollock ML. Practical assessment of body composition. Physic Sportsmed. 1985; 13: 76-90.
22. Cabrera MAS, Jacob Filho W. Obesidade em idosos: prevalência, distribuição e associação com hábitos e co-morbidades. Arq Bras Endocrinol Metab. 2001; 45: 494-501.
23. Sowers JR. Obesity and cardiovascular disease. Clin Chem. 1998; 44 (8): 1821-5.
24. Abate N. Obesity and cardiovascular disease: pathogenic role of metabolic syndrome and therapeutic implications. J Diabetes Complications. 2000; 14: 154-74.
25. Yudkin JS, Stehowe CD, Emeis J, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue. Arterioscler Thromb Vasc Biol. 1999; 19: 972-8.
26. Lemieux I, Pascot A, Prud'homme D, Alméras N, Bogaty P, Nadeauet A, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001; 21: 961-7.
27. Cabrera MAS, Wajngarten M, Gebara OCE, Diament J. Relação do índice de massa corporal, da relação cintura quadril e da circunferência abdominal com a mortalidade em mulheres idosas: seguimento de 5 anos. Cad Saúde Pública. 2005; 21: 767-75.
28. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107: 363-9.
29. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000; 23: 1835-9.
30. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000; 20: 1057-60.
31. Soinio M, Marniemi J, Laksoo M, Lehto S, Rönnemaa T. High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes. Diabetes Care. 2006; 29: 329-33.